Displaying 10 out of 8 results

  1. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche enters US$1.15 billion licensing deal for Sarepta gene therapy

    Roche entered into a US$1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta's ...
  2. Logo is seen at new factory of Novartis in Stein

    Novartis in talks with patients upset about lottery-like gene therapy giveaway

    Novartis is in discussion with patient groups over its lottery-style free drug program for its multi-million-dollar gene therapy for spinal ...
  3. FILE PHOTO: Swiss pharmaceutical group Lonza's world’s largest dedicated cell and gene therapy

    Pfizer, Novartis lead US$2 billion spending spree on gene therapy production

    Eleven drugmakers led by Pfizer and Novartis have set aside a combined US$2 billion to invest in gene therapy manufacturing since 2018, according ...
  4. The ticker and trading information for Blackstone Group is displayed at the post where it is traded

    Blackstone to invest US$400 million in gene therapy venture with Ferring

    Blackstone Group Inc said on Monday it will invest US$400 million in a joint venture with Swiss drug company Ferring that is working on an ...
  5. FILE PHOTO: Roche tablets are seen positioned in front of a displayed Roche logo in this photo illu

    FTC staff recommends approval of Roche deal for Spark: report

    The Federal Trade Commission staff reviewing Roche's plan to buy U.S.-based gene therapy specialist Spark Therapeutics for US$4.3 billion ...
  6. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis data suggest payers getting breaks on gene therapy Zolgensma

    Novartis sales data on Tuesday suggested the Swiss drugmaker is reaping less than the US$2.1 million U.S. list price for its gene therapy ...